EUVIMEDEUVIMED entdecken
Vergleichsstudie

Short‐Term Outcomes of Minimally‐Invasive Esophagectomy Compared to Thoracotomy and Transhiatal Approaches in Total Esophagectomy With Pharyngolaryngectomy

Ryoko Nozaki iD, Daisuke Kurita, Koshiro Ishiyama, Junya Oguma, Ryota Kakuta iD, Shota Igaue, Eigo Akimoto, Daichi Utsunomiya, Yasuyuki Seto, Hiroyuki Daiko

Asian Journal of Endoscopic Surgery · 2025

DOI: 10.1111/ases.70169 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Asian Journal of Endoscopic Surgery, 2025. Verfasst von Ryoko Nozaki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Esophageal Surgery Division, National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Esophagectomy, Laryngectomy, Esophageal Neoplasms, Pharyngectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Esophageal squamous cell carcinoma (ESCC) and squamous cell carcinoma of the head and neck (HN) often occur simultaneously. Total esophagectomy with pharyngolaryngectomy (TE‐TPL) is a highly invasive surgery associated with significant mortality. In thoracic esophagectomy, minimally invasive esophagectomy (MIE) has gained widespread acceptance. This study evaluates the efficacy of MIE in TE‐TPL.

Methods

We retrospectively analyzed patients who underwent TE‐TPL between January 2007 and December 2022 at the National Cancer Center Hospital in Tokyo, Japan. A total of 33 patients were enrolled, with 19 undergoing minimally invasive esophagectomy (MIE group) and 14 undergoing conventional esophagectomy (Open group).

Results

MIE was associated with a significantly shorter operative time (532 min vs. 687 min, p = 0.028), less intraoperative bleeding (371 mL vs. 840 mL, p < 0.01), shorter hospital stays (21 days vs. 34 days, p < 0.01), and a lower reoperation rate (11% vs. 29%, p = 0.036) compared to the Open group. The 3‐year overall survival (OS) and progression‐free survival (PFS) rates were not significantly different between the two groups (OS: 47.4% vs. 50.0%, p = 0.72; PFS: 34.0% vs. 47.1%, p = 0.41).

Conclusion

MIE may be a more feasible and efficient option than the conventional approach for TE‐TPL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EsophagectomyLaryngectomyEsophageal NeoplasmsPharyngectomyThoracotomyEsophageal Squamous Cell CarcinomaHumansMaleFemaleRetrospective StudiesMiddle AgedAgedTreatment OutcomeOperative TimeMinimally Invasive Surgical ProceduresLength of Stay

Stichwörter der Autor:innen

minimally‐invasive esophagectomypharyngolaryngectomytotal esophagectomy

Autor:innen und Institutionen

  • Esophageal Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
  • Course of Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, Tokyo, Japan.

ORCID-Profile: Ryoko Nozaki, Ryota Kakuta

Zitieren

APA

Nozaki, R., Kurita, D., Ishiyama, K., Oguma, J., Kakuta, R., Igaue, S., Akimoto, E., Utsunomiya, D., Seto, Y., & Daiko, H. (2025). Short‐Term Outcomes of Minimally‐Invasive Esophagectomy Compared to Thoracotomy and Transhiatal Approaches in Total Esophagectomy With Pharyngolaryngectomy. Asian Journal of Endoscopic Surgery. https://doi.org/10.1111/ases.70169

Vancouver

Nozaki R, Kurita D, Ishiyama K, Oguma J, Kakuta R, Igaue S, et al. Short‐Term Outcomes of Minimally‐Invasive Esophagectomy Compared to Thoracotomy and Transhiatal Approaches in Total Esophagectomy With Pharyngolaryngectomy. Asian Journal of Endoscopic Surgery. 2025. doi:10.1111/ases.70169

BibTeX
@article{Nozaki2025,
  author = {Nozaki, Ryoko and Kurita, Daisuke and Ishiyama, Koshiro and Oguma, Junya and Kakuta, Ryota and Igaue, Shota and Akimoto, Eigo and Utsunomiya, Daichi and Seto, Yasuyuki and Daiko, Hiroyuki},
  title = {Short‐Term Outcomes of Minimally‐Invasive Esophagectomy Compared to Thoracotomy and Transhiatal Approaches in Total Esophagectomy With Pharyngolaryngectomy},
  journal = {Asian Journal of Endoscopic Surgery},
  year = {2025},
  doi = {10.1111/ases.70169}
}
Kostenlos starten →